2-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACMYVH256
CAS No. :
2094504-02-4
Molecular Formula :
C18H22BNO2
Molecular Weight :
295.19

IUPAC Name:2-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$445.00Login to see priceInquiryInquiry
250mg95%$627.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name2-benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MDL No.MFCD31698379
Molecular FormulaC18H22BNO2
Molecular Weight295.19
SMILESCC1(OB(C2C=CC(CC3C=CC=CC=3)=NC=2)OC1(C)C)C
InChI KeyRGUQYAAWRLVFQC-UHFFFAOYSA-N
SynonymPyridine, 2-(phenylmethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;2-Benzyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
CAS No.2094504-02-4

Safety Data

Pictogram
Toxic
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMYVH256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACMYVH256 route product structure diagram
    ACMYVH2562094504-02-4
Inquiry

2. ACMYVH256 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRYEP305 route compound structure diagram
    ACRYEP305214360-62-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACMYVH256 route product structure diagram
    ACMYVH2562094504-02-4
Inquiry

Comments (0)